Axsome Therapeutics Inc (NASDAQ:AXSM)

68.34
Delayed Data
As of 3:59pm ET
 -3.69 / -5.12%
Today’s Change
35.44
Today|||52-Week Range
109.53
-16.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-10.6M-27.2M-28.9M-31.0M
 
 
 
 
 
Depreciation3.5K20.5K42.6K48.9K
 
 
 
 
 
Total Other Cash Flow2.2M2.1M3.2M-660.4K
 
 
 
 
 
Funds From Operations-8.4M-25.1M-25.7M-31.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-937.7K-3.8M759.5K-1.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-7.4M-21.3M-26.5M-30.1M
 
 
 
 
 
 
InvestingCapital Expenditures-20.2K-104.6K-9.9K-32.7K
 
 
 
 
 
Net Cash Flow Investing-20.2K-104.6K-9.9K-32.7K
 
 
 
 
 
 
FinancingShort Term Borrowings-41.5K0.000.000.00
 
 
Long Term Borrowings7.4M9.9M0.000.00
 
 
 
Long Term Debt Reduction--0.00-277.8K-3.3M
 
 
 
Net Proceeds Stock Sale45.5M33.0K24.2M13.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.0026.0K
 
 
Net Cash Flow - Financing52.9M10.0M23.9M10.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash45.4M-11.4M-2.6M-20.1M